Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support

  • Lim, Kyunghee (Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, Jin-Oh (Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Jeong Hoon (Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Seung-Jung (Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Sun Hwa (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Jiseok (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Joh, Hyun Sung (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Shin, Sun Hye (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2016.05.09
  • Accepted : 2016.09.13
  • Published : 2017.01.31
⟨ Previous Next ⟩

Abstract

A 65-year-old woman was admitted to our hospital with acute decompensated heart failure with reduced left ventricular ejection fraction and severe mitral regurgitation. Electrocardiography revealed a typical left bundle branch block and atrial fibrillation. Her condition deteriorated despite administering high-doses of inotropes and vasopressors. Pending a decision to therapy, venoarterial extracorporeal membrane oxygenation (ECMO) was performed when the patient underwent a cardiogenic shock. Although the hemodynamic status stabilized with ECMO support, weaning the patient from ECMO was not possible. Thus, we decided to perform cardiac resynchronization with defibrillator implantation as a "rescue" therapy. Five days post-implantation, the patient was successfully weaned from ECMO.

Keywords

References

  1. European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 2013;15:1070-118. https://doi.org/10.1093/europace/eut206
  2. National Institute for Health and Care Excellence. Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure [Internet]. London (UK); 2014 [cited 2014 June 24]. Available from: https://www.nice.org.uk/guidance/ta314.
  3. Mantziari L, Guha K, Senguttuvan NB, Sharma R. Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction. Int J Cardiol 2013;163:141-5. https://doi.org/10.1016/j.ijcard.2011.05.034
  4. Sokal A, Jedrzejczyk E, Lenarczyk R, et al. Efficacy of cardiac resynchronisation therapy in the treatment of end-stage inotropedependent heart failure patients. Kardiol Pol 2014;72:777-82. https://doi.org/10.5603/KP.a2014.0090
  5. Zaeem F, Giedriemiene D, Coleman C, et al. CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF. Cardiol Res Pract 2012;2012:319205.
  6. Bhattacharya S, Abebe K, Simon M, Saba S, Adelstein E. Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy. J Card Fail 2010;16:931-7. https://doi.org/10.1016/j.cardfail.2010.07.253
  7. Pecha S, Yildirim Y, Reichenspurner H, Deuse T. Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with endstage heart failure. Interact Cardiovasc Thorac Surg 2012;15:922-3. https://doi.org/10.1093/icvts/ivs338
  8. Bang JH, Oh YN, Ko JK, Kang SY, Baek JS, Park CS. Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator. Korean J Thorac Cardiovasc Surg 2015;48:55-8. https://doi.org/10.5090/kjtcs.2015.48.1.55
  9. Cowburn PJ, Patel H, Jolliffe RE, Wald RW, Parker JD. Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure? Eur J Heart Fail 2005;7:215-7. https://doi.org/10.1016/j.ejheart.2004.11.005
  10. Serri K, Lafitte S, Amyot R, Sauve C, Roudaut R. Echocardiographic evaluation of cardiac dyssynchrony. Can J Cardiol 2007;23:303-10. https://doi.org/10.1016/S0828-282X(07)70760-2
  11. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38. https://doi.org/10.1056/NEJMoa0906431
  12. Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825-31. https://doi.org/10.1016/S0735-1097(98)00492-6
  13. Upadhyay GA, Choudhry NK, Auricchio A, Ruskin J, Singh JP. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol 2008;52:1239-46. https://doi.org/10.1016/j.jacc.2008.06.043
  14. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75. https://doi.org/10.1093/eurheartj/ehi555
  15. Swedberg K, Komajda M, Bohm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010;376:875-85. https://doi.org/10.1016/S0140-6736(10)61198-1

Cited by

  1. Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response vol.14, pp.1, 2017, https://doi.org/10.1371/journal.pone.0210603